艾克美制药 ALKS
$45.90 +$1.36 (+3.05%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $46.01 +0.24%
开盘$44.19
昨收$44.54
当日区间$44.07 – $45.94
成交量1.67M
市值$7.71B
市盈率（TTM）–
股息率–
ALKS 相关新闻
匹配 Alkermes 或代码 ALKS 的头条新闻，按最新排序。
- Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65
- Goldman Sachs Initiates Alkermes(ALKS.US) With Hold Rating, Announces Target Price $50
- A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $56 to $83
- A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $38 to $65
- Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $78 正面
- Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65
- 4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
- Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65 正面
- A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $58 to $65
- Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65 正面
- Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $63 正面
- 4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
- J.P. Morgan Maintains Alkermes(ALKS.US) With Hold Rating, Raises Target Price to $60 正面
- Needham Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $62 正面
- TD Cowen Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $57 正面
暂无评论——快来第一个聊聊 ALKS。
登录后参与讨论。